The first product launch of Labiana Pharmaceuticals

Home / News / The first product launch of Labiana Pharmaceuticals

Labiana Pharmaceuticals launches in the market its own first medicine product: Fosfomicina Labiana.

After obtaining the marketing authorization, the product has burst with force in our country in this first year, placing itself above some products of the competition. The reasons for this success have undoubtedly been the great expertise on the molecule fosfomycin trometamol (as being the first laboratory which obtained the CEP), as well as the control of all manufacturing stages: from the active ingredient to the finished product.

Labiana Pharmaceuticals is also a manufacturer of fosfomycin for several countries and is expected to expand in a short time to many more, where marketing authorizations are being finalized. Interest in this medicine continues to grow and many agreements have already been signed with European, American, African and Asian companies. Encouraged by this success, in the coming years we will multiply efforts to expand the human medicine product portfolio Labiana Pharmaceuticals, with new projects in the area of ​​self-care.

Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle información relacionada con sus preferencias, mediante el análisis de sus hábitos de navegación. Si continúa navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información visitando nuestra Política de Cookies

We use own and third-party cookies to improve our services and show information related to your preferences by analyzing your browsing habits. If you continue browsing, we will consider that you allow us to use them. You can change the settings or get more information on our Cookies policy

Nous utilisons nos propres cookies et celles de tiers pour améliorer nos services et vous proposer des informations relatives à vos préférences, en analysant vos habitudes de navigation. Si vous poursuivez la navigation, nous estimons que vous acceptez l’utilisation des cookies. Vous pouvez modifier les paramètres ou obtenir plus d'informations en nous rendant visite sur notre politique relative aux cookies

Aviso de cookies